Acquisition Growth LINK Medical has a track record of strategic acquisitions including CRST Oy, expanding its Nordic footprint and enhancing its early-phase clinical service capabilities, signaling a potential need for integration consulting, harmonized regulatory processes, and cross-border CRO support.

Regulatory Leader With one of the largest regulatory teams in the Nordics and end-to-end regulatory services from pre-clinical to post-marketing, the company presents opportunities to upsell expanded regulatory affairs, health authority liaison, and global submissions for clients planning multinational trials.

Clinical Capacity Recent expansion into early-phase and First-in-Human studies via CRST acquisition indicates demand for scalable clinical trial support, including site management, patient recruitment, and data management solutions aligned to Nordic and international studies.

Strategic Partnerships Active collaborations with Lipigon Pharmaceuticals and ongoing industry partnerships suggest opportunities to offer joint development services, real-world evidence, analytics, and market access support to optimize go-to-market timelines.

Digital & Analytics Adoption of tools like Power BI and Piwik PRO Core signals openness to data-driven operations; a selling point for advanced CRO analytics, performance dashboards, and regulatory/compliance reporting enhancements for sponsors.